Selective serotonin re-uptake inhibitors beyond psychiatry: Are they useful in the treatment of severe, chronic, obstructive pulmonary disease?

Depression and Anxiety

Volumn 20, Issue 4, 2004, Pages 203-204

  Perna, Giampaolo ^a,c   Cogo, Roberto ^b   Bellodi, Laura ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b Cassano d'Adda Hospital   (Italy)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENERGIC RECEPTOR STIMULATING AGENT; CITALOPRAM; CORTICOSTEROID; DIURETIC AGENT; LORAZEPAM; METHYLXANTHINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; DYSPNEA; FORCED EXPIRATORY VOLUME; HEART RATE; HUMAN; HYPERVENTILATION; MEDICAL SOCIETY; OXYGEN SATURATION; OXYGEN THERAPY; PANIC; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRY; QUALITY OF LIFE; RESPIRATORY FUNCTION; REVIEW; SIDE EFFECT; SLEEP APNEA SYNDROME; THROMBOCYTE FUNCTION; WALKING;

AGED; CARBON DIOXIDE; CITALOPRAM; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 13444283499     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/da.20041     Document Type: Review

References (8)

1. Holtman JR Jr, Norman WP, Skirboll L, Dretchen KL, Cuello C, Visser TJ, Hokfelt T, Gillis RA. 1984. Evidence for 5-hydroxytryptamine, substance P, and thyrotropin-releasing hormone in neurons innervating the phrenic motor nucleus. J Neurosci 4:1064-1071.
2. Klein DF. 1994. Testing the suffocation false alarm theory of panic disorder. Anxiety 1:1-7.
3. Kraiczi H, Hedner J, Dahlof P, Ejnell H, Carlson J. 1999. Effect of serotonin uptake inhibition on breathing during sleep and daytime symptoms in obstructive sleep apnea. Sleep 22:61-67.
4. Papp LA, Weiss JR, Greenberg HE, Rifkin A, Scharf SM, Gorman JM, Klein DF. 1995. Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders. Am J Psychiatry 152:1531.
5. Serebruany VL, Glassman AH, Malinin AI, Atar D, Sane DC, Oshrine BR, Ferguson JJ, O'Connor CM. 2003. Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin. Eur J Heart Fail 5:517-521
6. Smoller JW, Pollack MH, Systrom D, Kradin RL. 1998. Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics 39:24-29.
7. Suhara T, Sudo Y, Yoshida K, Okubo Y, Fukuda H, Obata T, Yoshikawa K, Suzuki K, Sasaki Y. 1998. Lung as reservoir for antidepressants in pharmacokinetic drug interactions. Lancet 351:332-335.
8. Veasey SC, Panckeri KA, Hoffman EA, Pack AI, Hendricks JC. 1996. The effects of serotonin antagonists in an animal model of sleep-disordered breathing. Am J Respir Crit Care Med 153:776-786.